Abstract |
We report a young patient with a variant of juvenile idiopathic arthritis, who, after 4 years of infliximab treatment, developed miliary tuberculosis (TB) with central nervous system involvement ( meningitis and multiple tuberculomas). After anti-TB treatment, clinical and radiologic responses were observed, but severe cerebrospinal fluid and brain inflammatory reaction, nonresponsive to corticosteroids, persisted. It was considered a life-threatening paradoxical reaction based on initial cerebrospinal fluid isolation of Mycobacterium tuberculosis fully sensitive to primary anti-TB drugs. After 4 months in the hospital, infliximab was administered considering that infliximab is a potent tumor necrosis factor α inhibiting agent that participates in the formation and preservation of granulomas and may help to modulate the exaggerated cell-mediated immune response against mycobacterial antigens. Clinical complications associated to brain inflammation resolved, and after 3 years of follow-up, the patient remains self-sufficient without neurologic sequels.
|
Authors | Jaimes-Hernández Jorge, Cárdenas Graciela, Aranda-Pereira Pablo, Soto-Hernández José Luis |
Journal | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
(J Clin Rheumatol)
Vol. 18
Issue 4
Pg. 189-91
(Jun 2012)
ISSN: 1536-7355 [Electronic] United States |
PMID | 22647865
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antirheumatic Agents
- Antitubercular Agents
- Glucocorticoids
- Infliximab
|
Topics |
- Adult
- Antibodies, Monoclonal
(therapeutic use)
- Antirheumatic Agents
(therapeutic use)
- Antitubercular Agents
(therapeutic use)
- Arthritis, Juvenile
(drug therapy)
- Glucocorticoids
(therapeutic use)
- Humans
- Infliximab
- Magnetic Resonance Imaging
- Male
- Mycobacterium tuberculosis
(isolation & purification)
- Tomography, X-Ray Computed
- Tuberculosis, Meningeal
(drug therapy)
- Tuberculosis, Miliary
(drug therapy)
- Young Adult
|